C07D 217/18
Aralkyl radicals
C07D217/18 (Aralkyl radicals) appears on 229 US grants and 207 published applications in this corpus.
Search patents in C07D- Granted patents
- 229
- Published applications
- 207
- Assignees
- 168
- Inventors
- 755
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 9 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 6 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 0 |
| 2003 | 5 | 7 |
| 2004 | 4 | 10 |
| 2005 | 4 | 9 |
| 2006 | 3 | 10 |
| 2007 | 4 | 9 |
| 2008 | 3 | 10 |
| 2009 | 6 | 8 |
| 2010 | 6 | 15 |
| 2011 | 12 | 8 |
| 2012 | 10 | 3 |
| 2013 | 8 | 9 |
| 2014 | 8 | 11 |
| 2015 | 10 | 24 |
| 2016 | 5 | 9 |
| 2017 | 3 | 7 |
| 2018 | 1 | 2 |
| 2019 | 8 | 11 |
| 2020 | 5 | 2 |
| 2021 | 7 | 9 |
| 2022 | 3 | 6 |
| 2023 | 3 | 9 |
| 2024 | 3 | 4 |
| 2025 | 4 | 11 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound for treating Alzheimer's disease16 Jun 2026US 12,655,088 B2East China University of Science and Technology
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors25 Nov 2025US 12,479,797 B2Jubilant Epicore LLC
- 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof12 Aug 2025US 12,384,753 B2Enanta Pharmaceuticals, Inc.
- Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin17 Jun 2025US 12,329,762 B2Eli Lilly and Company
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Papd5 inhibitors and methods of use thereof30 Apr 2026US 2026/0115182 A1Children's Medical Center Corporation
- Tetrahydroisoquinolinylmethylbenzamide compounds19 Feb 2026US 2026/0049060 A1National Health Research Institutes
- Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin18 Dec 2025US 2025/0381199 A1Eli Lilly and Company
- 17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof11 Dec 2025US 2025/0376452 A1Enanta Pharmaceuticals, Inc.
Most cited
By later US patents
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Stilbene derivatives as anticancer agents78US 5,430,062 AResearch Corporation Technologies, Inc. · 1995
- Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl51US 4,613,668 AThe United States of America as represented by the Department of Health and Human Services · 1986
- Practical total synthesis unnatural enantiomers of opium-derived morphinans43US 4,521,601 AThe United States of America as represented by the Department of Health and Human Services · 1985
- Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them41US 6,911,453 B2Aventis Pharma Deutschland GmbH · 2005